Not Medicare Enrolled

Dr. Maurice Leibman, MD

Obstetrics & Gynecology · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
12727 KIMBERLEY LN, Houston, TX 77024
7132752990
In practice since 2005 (20 years)
NPI: 1023017001 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Leibman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Leibman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Leibman

Dr. Maurice Leibman is an obstetrics & gynecology specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Leibman performed 140 Medicare services across 125 unique beneficiaries.

Between the years covered by Open Payments, Dr. Leibman received a total of $29,062 from 47 pharmaceutical and/or device companies across 490 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in obstetrics & gynecology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Leibman is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 29% volume in TX $29,062 industry payments

Medicare Practice Summary

Medicare Utilization ↗
140
Medicare services
Top 29% in TX for obstetrics & gynecology
125
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min) 65 $55 $167
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous 29 $18 $64
Office visit, established patient (30-39 min) 20 $74 $302
Cervical or vaginal cancer screening; pelvic and clinical breast examination 14 $40 $85
Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina 12 $77 $417
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$29,062
Total received (2018-2024)
Avg $4,152/year across 7 years
Top 3% in TX for obstetrics & gynecology
47
Companies
490
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21,512 (74.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,550 (26.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,000
2023
$568
2022
$1,499
2021
$1,144
2020
$830
2019
$2,530
2018
$19,491

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AMAG Pharmaceuticals, Inc.
$18,512
ASCEND THERAPEUTICS US, LLC
$3,091
Acessa Health Inc.
$1,088
Novo Nordisk Inc
$927
TherapeuticsMD, Inc.
$612
Amgen Inc.
$567
AbbVie Inc.
$471
Vertical Pharmaceuticals, LLC
$418
PFIZER INC.
$296
MAYNE PHARMA INC.
$280
ASCEND Therapeutics US, LLC
$278
AbbVie, Inc.
$253
Astellas Pharma US Inc
$204
Myovant Sciences Inc.
$193
Exeltis, USA Inc.
$165
Bayer HealthCare Pharmaceuticals Inc.
$165
Davol Inc.
$162
Currax Pharmaceuticals LLC
$152
Lupin Inc.
$119
Avion Pharmaceuticals
$98
Kowa Pharmaceuticals America, Inc.
$91
ABBVIE INC.
$82
Sumitomo Pharma America, Inc.
$82
Allergan Inc.
$73
Hologic, LLC
$66
Takeda Pharmaceuticals U.S.A., Inc.
$66
Evofem Biosciences, Inc.
$59
Eisai Inc.
$55
MILLICENT US INC
$46
Organon LLC
$38
Allergan, Inc.
$33
IDORSIA PHARMACEUTICALS US INC
$31
Bayer Healthcare Pharmaceuticals Inc.
$30
Duchesnay USA Incorporated
$29
MAYNE PHARMA COMMERCIAL LLC
$26
Merck Sharp & Dohme Corporation
$25
SCYNEXIS, Inc.
$21
Allotrope Medical, Inc
$20
Shire North American Group Inc
$18
EISAI INC.
$18
Pacira Pharmaceuticals Incorporated
$18
Nalpropion Pharmaceuticals, Inc.
$16
Orexigen Therapeutics, Inc.
$16
Gynesonics, Inc.
$15
Sebela Pharmaceuticals Inc.
$12
Agile Therapeutics, Inc.
$11
Nalpropion Pharmaceuticals LLC
$11
Top 3 companies account for 78.1% of total payments
Associated products mentioned in payments ›
ACESSA PROVU SYSTEM · ANALPRAM · ANNOVERA · ARISTA AH FLEXITIP · Acessa · Aimovig · Aptima HPV · Aptima M genitalium · BINOSTO · Balcoltra · Belviq · CONTRAVE · DIVIGEL · Divigel · ESTROGEL · EVENITY · Exparel · Femring · GARDASIL 9 · IMVEXXY · INTRAROSA · Intrarosa · Kyleena · LILETTA · LO LOESTRIN FE · Lupron · MYFEMBREE · MYRBETRIQ · Mirena · MyoSure · NEXPLANON · Natazia · ORIAHNN · ORILISSA · Omniscope · Orilissa · Osphena · PREMARIN · PREMARIN ORALS · Phexxi · Prolia · QUVIVIQ · RELEXXII · SEGLENTIS · SLYND · SOLOSEC · SOLOSEC-CEEK · SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM · SPRIX · Saxenda · Seglentis · Solosec · StimSite · TRINTELLIX · Trintellix · Twirla · Veozah · Vitafol Ultra · Wegovy
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (74%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in obstetrics & gynecology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for obstetrics & gynecology in TX.

Equivalent to $20,758 per 100 Medicare services performed
Looking for an obstetrics & gynecology specialist in Houston?
Compare obstetricians & gynecologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse obstetricians & gynecologists nearby

Geographic Context

Obstetricians & gynecologists within 10 mi
770
Per 100K population
16.2
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Leibman is a clinical cardiology specialist, with above-average Medicare volume (top 29% in TX), with speaking/promotional industry engagement in the top 3% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Leibman experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Leibman performed 65 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Leibman receive payments from pharmaceutical companies?
Yes. Dr. Leibman received a total of $29,062 from 47 companies across 490 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Leibman's costs compare to other obstetricians & gynecologists in Houston?
Dr. Leibman's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Leibman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →